Interfacial engineering of pyridinium gemini surfactants for the generation of synthetic transfection systems

Biomaterials

Volumn 34, Issue 28, 2013, Pages 6906-6921

  Sharma, Vishnu D ^a   Aifuwa, Eronmwon O ^a   Heiney, Paul A ^b   Ilies, Marc A ^a,c  

^a TEMPLE UNIVERSITY SCHOOL OF PHARMACY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c TEMPLE UNIVERSITY   (United States)

Author keywords

DNA; DSC; Gene delivery; Nanoparticles; Self assembly; XRD

Indexed keywords

DSC; GENE DELIVERY; MOLECULAR FLEXIBILITY; PHYSICOCHEMICAL PROPERTY; STRUCTURE ACTIVITY RELATIONSHIPS; TRANSFECTION EFFICIENCY; XRD; ZETA POTENTIAL MEASUREMENTS;

AMPHIPHILES; DNA; DRUG THERAPY; GENE TRANSFER; NANOPARTICLES; SELF ASSEMBLY; X RAY DIFFRACTION; ZETA POTENTIAL;

EFFICIENCY;

AMPHOPHILE; LIPOSOME; PYRIDINIUM GEMINI SURFACTANT; SURFACTANT; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CHEMICAL STRUCTURE; CYTOTOXICITY; GENE DELIVERY SYSTEM; GENE TARGETING; GENETIC ENGINEERING; GENETIC TRANSFECTION; INTERFACIAL ENGINEERING; MICROSCOPY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SYNTHESIS; X RAY DIFFRACTION; ZETA POTENTIAL;

CELL LINE, TUMOR; CELL SURVIVAL; GENE TRANSFER TECHNIQUES; HUMANS; MOLECULAR STRUCTURE; PYRIDINIUM COMPOUNDS; STRUCTURE-ACTIVITY RELATIONSHIP; SURFACE-ACTIVE AGENTS; TRANSFECTION;

EID: 84879461905     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.05.029     Document Type: Article

References (59)

1. Kay M.A. State-of-the-art gene-based therapies; the road ahead. Nat Rev Genet 2011, 12(5):316-328.
2. Dotti G., Savoldo B., Okur F., Rousseau R.F., Brenner M.K. Gene therapy for the treatment of cancer: from laboratory to bedside. Gene Cell Ther 2009, 1001-1018. [3rd ed.].
3. Gao K., Huang L. Nonviral methods for siRNA delivery. Mol Pharm 2009, 6(3):651-658.
4. Li S.D., Huang L. Non-viral is superior to viral gene delivery. JControl Release 2007 Nov 20, 123(3):181-183.
5. Felgner P.L., Gadek T.R., Holm M., Roman R., Chan H.W., Wenz M., et al. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci U S A 1987, 84(21):7413-7417.
6. Kostarelos K., Miller A.D. Synthetic, self-assembly ABCD nanoparticles; a structural paradigm for viable synthetic non-viral vectors. Chem Soc Rev 2005 Nov, 34(11):970-994.
7. Li W., Szoka F.C. Lipid-based nanoparticles for nucleic acid delivery. Pharm Res 2007 Mar, 24(3):438-449.
8. Pinnaduwage P., Schmitt L., Huang L. Use of a quaternary ammonium detergent in liposome mediated DNA transfection of mouse L-cells. Biochim Biophys Acta 1989, 985:33-37.
9. Blessing T., Remy J.S., Behr J.P. Monomolecular collapse of plasmid DNA into stable virus-like particles. Proc Natl Acad Sci U S A 1998, 95(4):1427-1431.
10. Ilies M.A., Sommers T.V., He L.C., Kizewski A., Sharma V.D. Pyridinium amphiphiles in gene delivery - present and perspectives. Amphiphiles: molecular assembly and applications 2011, 23-38. ACS Symposium Series, Washington, DC. R. Nagarajan (Ed.).
11. Ilies M.A., Seitz W.A., Balaban A.T. Cationic lipids in gene delivery: principles, vector design and therapeutical applications. Curr Pharm Des. 2002, 8(27):2441-2473.
12. Martin B., Sainlos M., Aissaoui A., Oudrhiri N., Hauchecorne M., Vigneron J.P., et al. The design of cationic lipids for gene delivery. Curr Pharm Des. 2005, 11(3):375-394.
13. Bhattacharya S., Bajaj A. Advances in gene delivery through molecular design of cationic lipids. Chem Commun 2009, (31):4632-4656.
14. Srinivas R., Samanta S., Chaudhuri A. Cationic amphiphiles: promising carriers of genetic materials in gene therapy. Chem Soc Rev 2009, 38(12):3326-3338.
15. Barnard A., Posocco P., Pricl S., Calderon M., Haag R., Hwang M.E., et al. Degradable self-assembling dendrons for gene delivery: experimental and theoretical insights into the barriers to cellular uptake. JAm Chem Soc 2011, 133(50):20288-20300.
16. Mintzer M.A., Simanek E.E. Nonviral vectors for gene delivery. Chem Rev 2009, 109(2):259-302.
17. Hwang S.J., Davis M.E. Cationic polymers for gene delivery: designs for overcoming barriers to systemic administration. Curr Opin Mol Ther 2001, 3(2):183-191.
18. Midoux P., Pichon C., Yaouanc J.J., Jaffres P.A. Chemical vectors for gene delivery: a current review on polymers, peptides and lipids containing histidine or imidazole as nucleic acids carriers. Br J Pharmacol 2009, 157(2):166-178.
19. Schaffert D., Wagner E. Gene therapy progress and prospects: synthetic polymer-based systems. Gene Ther 2008, 15(16):1131-1138.
20. Shuvaev V.V., Ilies M.A., Simone E., Zaitsev S., Kim Y., Cai S.S., et al. Endothelial targeting of antibody-decorated polymeric filomicelles. ACS Nano 2011, 5(9):6991-6999.
21. Torchilin V.P. Multifunctional pharmaceutical nanocarriers: promises and problems. Nanotechnologies for the life sciences 2011, 121-155. Wiley-VCH, Weinheim. C. Kumar (Ed.).
22. Menger F.M., Keiper J.S. Gemini surfactants. Angew Chem Int Edit 2000, 39(11):1907-1920.
23. Gemini surfactants: synthesis, interfacial and solution-phase behavior, and applications 2004, Marcel Dekker, Inc, New York. R. Zana, J. Xia (Eds.).
24. Rosenzweig H.S., Rakhmanova V.A., MacDonald R.C. Diquaternary ammonium compounds as transfection agents. Bioconjug Chem 2001, 12(2):258-263.
25. van der Woude I., Wagenaar A., Meekel A.A., ter Beest M.B., Ruiters M.H., Engberts J.B., et al. Novel pyridinium surfactants for efficient, nontoxic invitro gene delivery. Proc Natl Acad Sci U S A 1997, 94(4):1160-1165.
26. Ilies M.A., Johnson B.H., Makori F., Miller A., Seitz W.A., Thompson E.B., et al. Pyridinium cationic lipids in gene delivery: an invitro and invivo comparison of transfection efficiency versus a tetraalkylammonium congener. Arch Biochem Biophys 2005, 435(1):217-226.
27. Ilies M.A., Seitz W.A., Johnson B.H., Ezell E.L., Miller A.L., Thompson E.B., et al. Lipophilic pyrylium salts in the synthesis of efficient pyridinium-based cationic lipids, gemini surfactants, and lipophilic oligomers for gene delivery. JMed Chem 2006, 49(13):3872-3887.
28. Wettig S.D., Verrall R.E., Foldvari M. Gemini surfactants: a new family of building blocks for non-viral gene delivery systems. Curr Gene Ther 2008, 8(1):9-23.
29. Bajaj A., Kondaiah P., Bhattacharya S. Synthesis and gene transfer activities of novel serum compatible cholesterol-based gemini lipids possessing oxyethylene-type spacers. Bioconjug Chem 2007, 18(5):1537-1546.
30. Wettig S.D., Badea I., Donkuru M., Verrall R.E., Foldvari M. Structural and transfection properties of amine-substituted gemini surfactant-based nanoparticles. JGene Med 2007, 9(8):649-658.
31. Biswas J., Mishra S.K., Kondaiah P., Bhattacharya S. Syntheses, transfection efficacy and cell toxicity properties of novel cholesterol-based gemini lipids having hydroxyethyl head group. Org Biomol Chem 2011, 9(12):4600-4613.
32. Kirby A.J., Camilleri P., Engberts J.B.F.N., Feiters M.C., Nolte R.J.M., Soderman O., et al. Gemini surfactants: new synthetic vectors for gene transfection. Angew Chem Int Edit 2003, 42(13):1448-1457.
33. Sharma V.D., Ilies M.A. Heterocyclic cationic gemini surfactants: a comparative overview of their synthesis, self-assembling, physicochemical, and biological properties. Med Res Rev 2012, Available from: http://onlinelibrary.wiley.com/doi/10.1002/med.21272/pdf (doi:10.1002/med.21272).
34. Israelachvili J.N., Mitchell D.J., Ninham B.W. Theory of self-assembly of hydrocarbon amphiphiles into micelles and bilayers. JChem Soc Faraday Trans 2 1976, 72:1525-1568.
35. Danino D., Talmon Y., Zana R. Alkanediyl-alpha, omega-bis(dimethylalkylammonium bromide) surfactants (Dimeric surfactants). 5. Aggregation and microstructure in aqueous-solutions. Langmuir 1995, 11(5):1448-1456.
36. Bernheim-Groswasser A., Zana R., Talmon Y. Sphere-to-cylinder transition in aqueous micellar solution of a dimeric (gemini) surfactant. JPhys Chem B 2000, 104(17):4005-4009.
37. Aswal V.K., De S., Goyal P.S., Bhattacharya S., Heenan R.K. Transition from disc to rod-like shape of 16-3-16 dimeric micelles in aqueous solutions. JChem Soc Faraday Trans 1998, 94(19):2965-2967.
38. Nagarajan R. Molecular packing parameter and surfactant self-assembly: the neglected role of the surfactant tail. Langmuir 2002, 18(1):31-38.
39. Lin A.J., Slack N.L., Ahmad A., George C.X., Samuel C.E., Safinya C.R. Three-dimensional imaging of lipid gene-carriers: membrane charge density controls universal transfection behavior in lamellar cationic liposome-DNA complexes. Biophys J 2003, 84(5):3307-3316.
40. Meekel A.A.P., Wagenaar A., Smisterova J., Kroeze J.E., Haadsma P., Bosgraaf B., et al. Synthesis of pyridinium amphiphiles used for transfection and some characteristics of amphiphile/DNA complex formation. Eur J Org Chem 2000, 665-673.
41. Quagliotto P., Viscardi G., Barolo C., Barni E., Bellinvia S., Fisicaro E., et al. Gemini pyridinium surfactants: synthesis and conductometric study of a novel class of amphiphiles. JOrg Chem 2003, 68(20):7651-7660.
42. Zhou L.M., Jiang X.H., Li Y.T., Chen Z., Hu X.Q. Synthesis and properties of a novel class of gemini pyridinium surfactants. Langmuir 2007, 23(23):11404-11408.
43. Balaban A.T., Stepan E. Reactions of pyrylium salts with nucleophiles. XIX. Novel bispyridinium salts with potential biological activity. Rev Roum Chim 1987, 32(2):155-177.
44. Bajaj A., Kondaiah P., Bhattacharya S. Effect of the nature of the spacer on gene transfer efficacies of novel thiocholesterol derived gemini lipids in different cell lines: a structure-activity investigation. JMed Chem 2008, 51(8):2533-2540.
45. Bajaj A., Kondaiah P., Bhattacharya S. Gene transfection efficacies of novel cationic gemini lipids possessing aromatic backbone and oxyethylene spacers. Biomacromolecules 2008, 9(3):991-999.
46. Ilies M.A., Seitz W.A., Ghiviriga I., Johnson B.H., Miller A., Thompson E.B., et al. Pyridinium cationic lipids in gene delivery: a structure-activity correlation study. JMed Chem 2004, 47(15):3744-3754.
47. Ilies M.A., Seitz W.A., Caproiu M.T., Wentz M., Garfield R.E., Balaban A.T. Pyridinium-based cationic lipids as gene-transfer agents. Eur J Org Chem 2003, 2645-2655.
48. Aberle A.M., Bennett M.J., Malone R.W., Nantz M.H. The counterion influence on cationic lipid-mediated transfection of plasmid DNA. Biochim Biophys Acta 1996, 1299(3):281-283.
49. Manet S., Karpichev Y., Bassani D., Kiagus-Ahmad R., Oda R. Counteranion effect on micellization of cationic gemini surfactants 14-2-14: Hofmeister and other counterions. Langmuir 2010, 26(13):10645-10656.
50. Nostro P.L., Nostro A.L., Ninham B.W., Pesavento G., Fratoni L., Baglioni P. Hofmeister specific ion effects in two biological systems. Curr Opin Colloid Interface Sci 2004, 9(1-2):97-101.
51. Bijma K., Engberts J.B.F.N. Effect of counterions on properties of micelles formed by alkylpyridinium surfactants.1. Conductometry and H-1-NMR chemical shifts. Langmuir 1997, 13(18):4843-4849.
52. Wagner K., Harries D., May S., Kahl V., Radler J.O., Ben-Shaul A. Direct evidence for counterion release upon cationic lipid-DNA condensation. Langmuir 2000, 16:303-306.
53. Collins K.D., Washabaugh M.W. The Hofmeister effect and the behaviour of water at interfaces. QRev Biophys 1985, 18(4):323-422.
54. Balaban A.T., Ilies M.A., Eichhofer A., Balaban T.S. Molecular and crystal structure of a self-assembling pyridinium cationic lipid. JMol Struct 2010, 984:228-231.
55. Earle M.J., Seddon K.R. Ionic liquids. Green solvents for the future. Pure Appl Chem 2000, 72(7):1391-1398.
56. Petrie S.E.B. Smectic liquid crystals. Liquid crystals 1979, 163-202. Marcel Dekker, New York. F.D. Saeva (Ed.).
57. Koltover I., Salditt T., Radler J.O., Safinya C.R. An inverted hexagonal phase of cationic liposome-DNA complexes related to DNA release and delivery. Science 1998, 281(5373):78-81.
58. Heerklotz H. Interactions of surfactants with lipid membranes. QRev Biophys 2008, 41(3-4):205-264.
59. Conwell C.C., Liu F., Huang L. Several serum proteins significantly decrease inflammatory response to lipid-based non-viral vectors. Mol Ther 2008, 16(2):370-377.